Altérations du métabolisme de l'homocystéine et maladies cardiovasculaires

Revue Francaise des Laboratoires

Volumn 1998, Issue 307, 1998, Pages 33-44

  Durand, Philippe ^a   Prost, Michel ^b   Blache, Denis ^a  

^a UNIVERSITÉ DE BOURGOGNE   (France)

^b Ctr Europ de Rech et d'Analyses   (France)

Author keywords

Atherosclerosis; Folates; Homocysteine; Methionine; Thrombosis

Indexed keywords

EID: 1642549607     PISSN: 03389898     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0338-9898(98)80217-5     Document Type: Article

References (50)

1. Blom H.J., Kleinveld H.A., Boers G.H.J., Demacker P.N.M., Hak-Lemmers H.L.M., Te Poele Pothoff M.T.W.B., et al., Lipid peroxidation and susceptibility of low-density lipoprotein to in vitro oxidation in hyperhomocysteinaemia, Eur. J. Clin. Invest. 25 (1995) 149-154.
2. Bostom A.G., Jacques P.F., Nadeau M.R., Williams R.R., Ellison R.C., Selhub J., Post-methionine load hyperhomocysteinemia in persons with normal fasting total plasma homocysteine: initial results from the NHLBI Family Heart Study, Atherosclerosis 116 (1995) 147-151.
3. Boushey C.J., Beresford S.A.A., Omenn G.S., Motulsky A.G., A quantitative assessment of plasma homocysteine as a risk factor for vascular disease, Probable benefits of increasing folic acid intakes, JAMA 274 (1995) 1049-1057.
4. Brattström L., Vitamins as homocysteine-lowering agents, J. Nutr. 126 (1996) 1276S-1280S.
5. Clarke R., Daly L., Robinson K., Naughten E., Cahalane S., Fowker B., et al., Hyperhomocysteinemia: an independent risk factor for vascular disease, N. Engl. J. Med. 324 (1991) 1149-1155.
6. D'Angelo A., Selhub J., Homocysteine and thrombotic disease, Blood 90 (1997) 1-11.
7. Den Heijer M., Koster T., Blom H.J., Bos G.M.J., Briet E., Reitsma P.H., et al., Hyperhomocysteinemia as a risk factor for deep-vein thrombosis, N. Engl. J. Med. 334 (1996) 759-762.
8. Di Minno G., Davi G., Margaglione M., Cirillo F., Grandone E., Ciabattoni G. et al., Abnormally high thromboxane biosynthesis in homozygous homocystinuria, Evidence for platelet involvement and probucol-sensitive mechanism, J. Clin. Invest. 92 (1993) 1400-1406.
9. Dudman N.P.B., Wilcken D.E.L., Stocker R., Circulating lipid hydroperoxide levels in human hyperhomocysteinemia, Relevance to development of arteriosclerosis, Arterioscler. Thomb. Vasc. Biol. 13 (1993) 512-516.
10. Durand P., Fortin L.J., Lussier-Cacan S., Davignon J., Blache D., Hyperhomocysteinemia induced by folic acid deficiency and methionine load, Applications of a modified HPLC method, Clin. Chim. Acta 252 (1996) 83-93.
11. Durand P., Lussier-Cacan S., Blache D., Acute methionine load-induced hyperhomocysteinemia enhances platelet aggregation, thromboxane biosynthesis and macrophage-derived tissue factor activity in rats, FASEB J. 11 (1997) 1157-1168.
12. Durand P., Prost M., Blache D., Pro-thrombotic effects of a folic acid deficient diet in rat platelets and macrophages related to elevated homocysteine and decreased n-3 polyunsaturated fatty acids, Atherosclerosis 121 (1996) 231-243.
13. Falcon C.R., Cattaneo M., Panzeri D., Martinelli I., Mannucci P.M., High prevalence of hyperhomocyst(e)inemia in patients with juvenile venous thrombosis, Arterioscler. Thromb. 14 (1994) 1080-1083.
14. Finkelstein J.D., Methionine metabolism in mammals, J. Nutr. Biochem. 1 (1990) 228-237.
15. Frosst P., Blom H.J., Milos R., Goyette P., Sheppard C.A., Mattews R.G., et al., A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase, Nature Genet. 10 (1995) 111-113.
16. Graham I.M., Daly L.E., Refsum H.M., Robinson K., Brattström L.E., Ueland P.M., et al., Plasma homocysteine as a risk factor for vascular disease, The European concerted action project, JAMA 277 (1997): 1775-1781.
17. Halvorsen B., Brude I., Drevon C.A., Nysom J., Ose L., Christiansen E.N., et al., Effect of homocysteine on copper ion-catalyzed, azo compound-initiated, and mononuclear cell-mediated oxidative modification of low density lipoprotein, J. Lipid Res. 37 (1996) 1591-1600.
18. Harker L.A., Ross R., Slichter S.J., Scott C.R., Homocystine-induced arterioslerosis, The role of endothelial cell injury and platelet response in its genesis, J. Clin. Invest. 58 (1976) 731-741.
19. Harpel P.C., Zhang X.X., Borth W., Homocysteine and hemostasis: pathogenetic mechanisms predisposing to thrombosis, J. Nutr. 126 (1996) 1285S-1289S.
20. Hopkins P.N., Wu L.L., Wu J., Hunt S.C., James B.C., Vincent G.M., et al., Higher plasma homocyst(e)ine and increased susceptibility to adverse effects of low folate in early familial coronary artery disease., Arterioscler. Thomb. Vasc. Biol. 15 (1995) 1314-1320.
21. Jacques P.F., Bostom A.G., Williams R.R., Ellison R.C., Eckfeldt J.H., Rosenberg I.H., et al., Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations, Circulation 93 (1996) 7-9.
22. Jakubowski H., Metabolism of homocysteine thiolactone in human cell cultures, Possible mechanism for pathological consequences of elevated homocysteine levels, J. Biol. Chem. 272 (1997) 1935-1942.
23. Kang S.S., Wong P.W.K., Malinow M.R., Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease, Ann. Rev. Nutr. 12 (1992) 279-298.
24. Lentz S.R., Sobey C.G., Piegors D.J., Bhopatkar M.Y., Faraci F.M., Malinow M.R., et al., Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia, J. Clin. Invest. 98 (1996) 24-29.
25. Loscalzo J., The oxidant stress of hyperhomocyst(e)inemia, J. Clin. Invest. 98 (1996) 5-7.
26. Lubec B., Fang-Kircher S., Lubec T., Blom H.J., Boers G.H.J., Evidence for McKusick's hypothesis of deficient collagen cross-linking in patients with homocystinuria. Biochim. Biophys. Acta: Mol. Basis Dis. 1315 (1996) 159-162.
27. Lubec B., Labudova O., Hoeger H., Muehl A., Fang-Klircher S., Marx M., et al., Homocysteine increases cyclin-dependent kinase in aortic rat tissue., Circulation 94 (1996) 2620-2625.
28. Malinow M.R., Homocyst(e)ine and arterial occlusive diseases, J. Intern. Med. 236 (1994) 603-617.
29. McCully K.S., Homocysteine theory of arteriosclerosis development and current status, Atherosclerosis Rev. 11 (1983) 157-246.
30. McCully K.S., Homocysteine and vascular disease, Nature Med. 2 (1996) 386-389.
31. Miller J.W., Nadeau M.R., Smith D., Selhub J., Vitamin B-6 deficiency vs folate deficiency: comparison of responses to methionine loading in rats, Am. J. Clin. Nutr. 59 (1994) 1033-1039.
32. Miller J.W., Nadeau M.R., Smith J., Smith D., Selhub J., Folate-deficiency-induced homocysteinaemia in rats: disruption of S-adenosylmethionine's co-ordinate regulation of homocysteine metabolism, Biochem. J. 298 (1994) 415-419.
33. Mudd S.H., Levy H.L., Scovby F., Disorders of transsulfuration. In: Scriver C.R., Beauded A.L., Sly W.S., Valle D., (Eds.), The metabolic and molecular basis of inherited disease, 7th ed., MacGrawHill, New York, 1995, pp. 1279-1237.
34. Nygård O., Vollset S.E., Refsum H., Stensvold, Tverdal A., Nordrehaug J.E., et al., Total plasma homocysteine and cardiovascular risk profile, The Hordaland homocysteine study, JAMA 274 (1995) 1526-1533.
35. Prost M., Process for the determination by means of free radicals of the antioxidant properties of a living organism or a potentially aggressive agents, US Patent 5 (135) (1992) p. 850.
36. Reis R.P., Azinheira J., Reis H.P., Bordalo A., Santos L., Adao M. et al., Homocysteinaemia after methionine overload as a coronary artery disease risk factor: importance of age and homocysteine levels, Coron. Art. Dis. 6 (1995) 851-856.
37. Rimm E.B., Willett W.C., Hu F.B., Sampson L., Colditz G.A., Manson J.E et al., Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women, JAMA 279 (1998) 359-364.
38. Robinson K., Arheart K., Refsum H., Brattström L., Boers G., Ueland P. et al., Low circulating folate and vitamin B6 concentrations, Risk factors for stroke, peripheral vascular disease, and coronary artery disease, Circulation 97 (1998) 437-443.
39. Selhub J., Jacques P.F., Wilson P.W.F., Rush D., Rosenberg I.H., Vitamin status and intake as primary determinants of homocysteinemia in an elderly population, JAMA 270 (1993) 2693-2698.
40. Selhub J., Miller J.W., The pathogenesis of homocysteinemia: interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine, Am. J. Clin. Nutr. 55 (1992) 131-138.
41. Silberberg J., Crooks R., Fryer J., Wlodarczyk J., Nair B., Guo X.W., et al., Gender differences and other determinants of the rise in plasma homocysteine after L-methionine loading, Atherosclerosis 133 (1997) 105-110.
42. Stamler J.S., Osborne J.A., Jaraki O., Rabbani L.E., Mullins M., Singel D., et al., Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen, J. Clin. Invest. 91 (1993) 308-318.
43. Stampfer M.J., Malinow M.R., Willett W.C., Newcomer L.M., Upson B., Ullmann D., et al, A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians, JAMA 268 (1992) 877-881.
44. Toborek M., Hennig B., Dietary methionine imbalance, endothelial cell dysfunction and atherosclerosis, Nutr. Res. 16 (1996) 1251-1266.
45. Tsai J.C., Perrella M.A., Yoshizumi M., Hsieh C.-M., Haber E., Schlegel R., et al., Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis, Proc. Natl. Acad. Sci. USA 91 (1994) 6369-6373.
46. Ubbink J.B., Vitamin nutrition status and homocysteine: An atherogenic risk factor, Nutr. Rev. 52 (1994) 383-387.
47. Ueland P.M., Mansoor M.A., Guttormsen A.B., Müller F., Aukrust P., Refsum H., et al., Reduced, oxidized and protein-bound forms of homocysteine and other aminothiols in plasma comprise the redox thiol status, A possible element of the extracellular antioxidant defense system, J. Nutr. 126 (1996) 1281S-1284S.
48. Ueland P.M., Refsum H., Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy, J. Lab. Clin. Med. 114 (1989) 473-501.
49. Ueland P.M., Refsum H., Stabler S.P., Malinow M.R., Andersson A., Allen R.H., Total homocysteine in plasma or serum: Methods and clinical applications, Clin. Chem. 39 (1993) 1764-1779.
50. Woo K.S., Chook P., Lolin Y.I., Cheung A.S.P., Chan L.T., Sun Y.Y., Sanderson J.E., et al., Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans, Circulation 96 (1997) 2542-2544.